• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553660
Device Problems Use of Device Problem (1670); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Death (1802); Hemorrhage/Bleeding (1888)
Event Date 02/27/2019
Event Type  Death  
Manufacturer Narrative
Age or date of birth: patient's exact age is unknown; however it was reported that the patient was around (b)(6).Lot #, manufacture date: the complainant was unable to report the lot number; therefore, the manufacture date and expiration date are unknown.The complainant indicated that the device has been disposed of and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific on march 18, 2019 that a hot axios stent was successfully implanted in a transgastric position to treat a pancreatic cyst during a stent placement procedure performed on (b)(6) 2019.Endoscopic ultrasound (eus) doppler was performed on the cyst prior to stent placement.A double pigtail stent was placed through the axios stent to ensure that the back wall of the cyst did not collapse and embed into the stent.Necrosectomy was performed for two weeks following stent placement.Reportedly, the patient's pancreas was very scarred due to the cyst and necrosis.According to the complainant, on (b)(6) 2019, during a necrosectomy with axios removal procedure, the physician removed the stent using rat tooth forceps and noticed blood immediately following the stent as it was removed through the esophagus.Reportedly, the patient's cyst had resolved at the time of the stent removal procedure and eus doppler was not performed prior to the stent removal.In the physician's assessment, the bleeding may have been caused by the stent rubbing against the patient's friable tissue and eroding the splenic artery.The patient suffered a severe bleed and died.The complainant reported that there was no malfunction of the axios stent noted.
 
Event Description
It was reported to boston scientific on (b)(6) 2019 that a hot axios stent was successfully implanted in a transgastric position to treat a pancreatic cyst during a stent placement procedure performed on (b)(6) 2019.Endoscopic ultrasound (eus) doppler was performed on the cyst prior to stent placement.A double pigtail stent was placed through the axios stent to ensure that the back wall of the cyst did not collapse and embed into the stent.Necrosectomy was performed for two weeks following stent placement.Reportedly, the patient's pancreas was very scarred due to the cyst and necrosis.According to the complainant, on (b)(6) 2019, during a necrosectomy with axios removal procedure, the physician removed the stent using rat tooth forceps and noticed blood immediately following the stent as it was removed through the esophagus.Reportedly, the patient's cyst had resolved at the time of the stent removal procedure and eus doppler was not performed prior to the stent removal.In the physician's assessment, the bleeding may have been caused by the stent rubbing against the patient's friable tissue and eroding the splenic artery.The patient suffered a severe bleed and died.The complainant reported that there was no malfunction of the axios stent noted.Additional information received on 16apr2019: reportedly, the patient's cyst contained 60-70% necrotic material.Note: the stent was placed to treat a cyst with over 30% necrotic material; however, the hot axios stent and delivery system is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts: 6cm in size and walled-off necrosis: 6cm in size with: 70% fluid content that are adherent to the gastric or bowel wall.
 
Manufacturer Narrative
Patient's exact age is unknown; however it was reported that the patient was around 70 years old.The complainant was unable to report the lot number; therefore, the manufacture date and expiration date are unknown.The complainant indicated that the device has been disposed of and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key8511367
MDR Text Key141833685
Report Number3005099803-2019-01690
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729951179
UDI-Public08714729951179
Combination Product (y/n)N
PMA/PMN Number
K163272
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/12/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model NumberM00553660
Device Catalogue Number50270
Was Device Available for Evaluation? No
Date Manufacturer Received04/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-